AGENT FOR TREATMENT AND PROPHYLAXIS OF INTESTINE DISBACTERIOSIS AND DYSFUNCTION

摘要

FIELD: medicine, gastroenterology, pediatry, gynecology. SUBSTANCE: agent containing bifidobacteria has additionally lysozyme at amount 5-20 mg per one drug dose at bifidobacteria content 10- 10CFU (colony-forming units). Preparation is used orally, locally and intravaginally by 2.5-15 doses/day for 1-3 weeks in children and adult of all ages. EFFECT: enhanced effectiveness of agent for prophylaxis and treatment.